about fansalaran
FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans...
Zealand Pharma may sell future obesity drug direct to patients
Zealand Pharma (ZELA.CO), opens new tab is considering a...
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria...
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of...
Northeast U.S. States Form Public Health Alliance in Response to Federal Vaccine Limits
Seven northeastern U.S. states, including New York, Pennsylvania, New...
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans...
Zealand Pharma may sell future obesity drug direct to patients
Zealand Pharma (ZELA.CO), opens new tab is considering a...
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria...
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of...
Northeast U.S. States Form Public Health Alliance in Response to Federal Vaccine Limits
Seven northeastern U.S. states, including New York, Pennsylvania, New...
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans...
Zealand Pharma may sell future obesity drug direct to patients
Zealand Pharma (ZELA.CO), opens new tab is considering a...
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria...
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of...
Northeast U.S. States Form Public Health Alliance in Response to Federal Vaccine Limits
Seven northeastern U.S. states, including New York, Pennsylvania, New...
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans...
Zealand Pharma may sell future obesity drug direct to patients
Zealand Pharma (ZELA.CO), opens new tab is considering a...
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria...
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of...
Northeast U.S. States Form Public Health Alliance in Response to Federal Vaccine Limits
Seven northeastern U.S. states, including New York, Pennsylvania, New...
"Fansalaran showcases the latest news and the top pharmaceutical brands in the country. With Fansalaran, you can be seen globally."
Headlines
Bristol Myers plans UK launch of schizophrenia drug Cobenfy, matching US price
Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans...
Zealand Pharma may sell future obesity drug direct to patients
Zealand Pharma (ZELA.CO), opens new tab is considering a...
Press Release: Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion
Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria...
FDA approves drug that Trump due to suggest as autism treatment
The U.S. Food and Drug Administration announced approval of...
Fansalaran
Get important news delivered directly to your inbox and stay connected!